6/15/2023 Flashcards
Lamotrigine MOA
Inhibits the release of glutamate and inhibits voltage-sensitive sodium channels, which stabilizes neuronal membranes. Also has weak inhibitory effect on the 5-HT3 receptor.
Lamotrigine class
Miscellaneous antiseizure agent - broad spectrum
Prevacid
Lansoprazole
Xalatan
Latanoprost
Latanoprost MOA
Prostaglandin analog; reduces intraocular pressure by increasing uveoscleral outflow.
Levetiracetam MOA
Synaptic vesicle protein inhibitor
Levetiracetam class
Antiseizure agent, broad spectrum
Levofloxacin MOA
Inhibits DNA-gyrase in susceptible organisms, thereby inhibiting relaxation of supercoiled DNA and promotes breakage of DNA strands. DNA gyrase (topoisomerase II) is essential to maintaining the superhelical structure of DNA and is required for DNA replication and transcription, DNA repair, recombination, and transposition.
Levofloxacin class
Fluoroquinolone
Linzess
Linaclotide
Linaclotide MOA
Bind and agonize guanylate cyclase-C on luminal surface of intestinal epithelium; results in chloride and bicarbonate secretion into the intestinal lumen. Intestinal fluid increases and GI transit is accelerated.
Linaclotide class
GI agent; guanylate cyclase-C agonist
Zyvox
Linezolid
Linezolid class
Oxazolidinone antibiotic
Linezolid MOA
Inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunit. This prevents the formation of the functional 70S complex that is essential for bacterial translation process.
Lithobid
Lithium
Lithium MOA
neuroprotective and neuroproliferative effects; modulates neurotransmission (enhances serotonin activity, inhibits excitatory neurotransmitters dopamine and glutamate, promotes GABA-mediated neurotransmission); also has cellular mechanisms including inhibition of intracellular proteins and also has effects on second messenger systems
Lithium class
Mood stabilizer; antimanic agent
Loperamide MOA
Acts directly on circular and longitudinal intestinal muscles through the opioid receptor to inhibit peristalsis and prolong transit time. Reduces fecal volume, increases viscosity, and diminishes fluid and electrolyte loss. Also increases tone on the anal sphincter.
Latuda
Lurasidone
Lurasidone MOA
Mixed serotonin-dopamine antagonist activity. Decreases dopamine activity in the mesolimbic pathway - reduced positive symptoms;
Increases dopamine release (due to 5-HT2A antagonism) in the mesocortical pathway - reduced negative and cognitive symptoms
Increased dopamine release (due to 5-HT2A antagonism) in the nigrostriatal and tuberoinfundibular pathways, leading to less risk of EPS and hyperprolactinemia, respectively.
Lurasidone class
Second generation antipsychotic